About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Losartan Therapy in Pulmonary Hypertension | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00519870

Losartan Therapy in Pulmonary Hypertension

In addition to being effective vasodilators, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) exert neurohumoral inhibitory actions, such as the inhibition of ...

Lead sponsor: Baskent University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Baskent University

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Pulmonary hypertension diagnosed by Doppler echocardiographic examination (a mean pulmonary artery pressure of \> 26mmHg)

Exclusion Criteria

•acute infectious or inflammatory disease,
•exacerbation of chronic obstructive pulmonary disease,
•malignancy,
•acute coronary syndrome in the last 4 weeks,
•uncontrolled arrhythmia and hypertension,
•decompensated heart failure,
•acute pulmonary emboli,
•thrombus in a lower extremity,
•oxygen saturation below 85% at rest,
•failure to cooperate with CPET

Related studies

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

Development of Novel Physiological CMR Methods in Health and Disease

NCT03854071 · Heart Failure, Pulmonary Hypertension, and more

RECRUITINGPhase 2

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820 · Pulmonary Hypertension

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

NCT07477197 · Adult Congenital Heart Disease, Pulmonary Hypertension, and more

RECRUITINGPhase 1

Preliminary Human Trials of F230 Tablets

NCT06899815 · Pulmonary Hypertension

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 23, 2007Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment—

Start dateJan 2005

Last updatedAug 23, 2007

Condition

Pulmonary Hypertension

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 23, 2007Data synced to Clareo: June 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions